The United States Food and Drug Administration (FDA) is making a significant move to permanently authorize the rare pediatric disease…
Read More

The United States Food and Drug Administration (FDA) is making a significant move to permanently authorize the rare pediatric disease…
Read More
The US Food and Drug Administration (FDA) is set to convene a significant public hearing on June 12, 2026, a…
Read More